Your browser doesn't support javascript.
loading
Stakeholders' Involvement in Health Technology Assessment in Kazakhstan, Poland and Bulgaria.
Kulembekova, Lyazzat; Hailey, David; Kulzhanov, Maksut; Tabarov, Adlet; Georgiev, Svetlin; Jaworzynska, Magdalena; Yanakieva, Antoniya Yordanova; Kosherbayeva, Lyazzat.
Afiliación
  • Kulembekova L; Health Policy and Management Department, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Hailey D; School of Information Sciences and Computer Technology, University of Wollongong, Wollongong, Australia.
  • Kulzhanov M; Health Policy and Management Department, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Tabarov A; Deputy Director of the National Center for Health Development, Ministry of Health, Astana, Kazakhstan.
  • Georgiev S; Department HTA, Faculty of Public Health "prof. Tzecomir Vodenitcharov, MD, PhD, Dsc", Medical University, Sofia, Bulgaria.
  • Jaworzynska M; Faculty of Economics, Maria Curie-Sklodowska University, Lublin, Poland.
  • Yanakieva AY; Department HTA, Faculty of Public Health "prof. Tzecomir Vodenitcharov, MD, PhD, Dsc", Medical University, Sofia, Bulgaria.
  • Kosherbayeva L; Health Policy and Management Department, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Patient Prefer Adherence ; 18: 1009-1015, 2024.
Article en En | MEDLINE | ID: mdl-38798950
ABSTRACT

Background:

In recent years, involvement of healthcare stakeholders in health technology assessment (HTA) has been discussed as helping the inclusion of social values in the decision-making process. The aim of our research was to identify and compare details from Kazakhstan, Poland and Bulgaria on their stakeholders' involvement in the HTA process. Information was sought on their identification, responsibilities, and regulation.

Methods:

We conducted a survey of seven types of stakeholders in the healthcare systems of Kazakhstan, Poland, and Bulgaria. They included patients and the public, providers, purchasers, payers, policy makers, product makers, and principal investigators. They were questioned on their involvement in the HTA process, and on the objectives of their participation.

Results:

Levels of involvement of different kinds of stakeholder varied between countries, reflecting political and administrative developments. There was full or partial agreement on the objectives of stakeholder participation. All respondents agreed that representatives of the ministry of health should be involved in selection of stakeholders for HTA.

Conclusion:

Progress has been made in the involvement of stakeholders, with interest in further development in all three countries.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Patient Prefer Adherence Año: 2024 Tipo del documento: Article País de afiliación: Kazajstán Pais de publicación: Nueva Zelanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Patient Prefer Adherence Año: 2024 Tipo del documento: Article País de afiliación: Kazajstán Pais de publicación: Nueva Zelanda